News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
VIKING GLOBAL INVESTORS LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.7% stake in Pharvaris N.V. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 4% stake in Guardant Health, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 7% stake in Amylyx Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 10% stake in Trevi Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 15.2% stake in Inhibrx, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in FIGS, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 17.4% stake in APi Group Corporation |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.5% stake in Standard BioTools Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.4% stake in Ginkgo Bioworks Holdings, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in COUPA SOFTWARE INCORPORATED |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 6.5% stake in PepGen Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Celldex Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in PROCEPT BioRobotics Corporation |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 7% stake in Edgewise Therapeutics, Inc. |
| 02/14/2023 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Orion Acquisition Corp. |
| 09/09/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 9.9% stake in Amylyx Pharmaceuticals, Inc. |
| 03/22/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 8.4% stake in PROCEPT BioRobotics Corporation |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 8.8% stake in FIGS, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Nuance Communications, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 12.3% stake in 4D Molecular Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 8.9% stake in Orion Acquisition Corp. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in Athira Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 14% stake in Inhibrix, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 5.5% stake in Edgewise Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in MUDRICK CAPITAL ACQUISITION CORPORATION II |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 7.4% stake in Pharvaris N.V. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 3.9% stake in PMV Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 11.3% stake in PROCEPT BioRobotics Corporation |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 13.1% stake in Rallybio Corporation |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 4.7% stake in Zentalis Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 8% stake in Talaris Therapeutics, Inc. |
| 02/14/2022 |
SC 13G/A
| VIKING GLOBAL INVESTORS LP reports a 0% stake in AbCellera Biologics Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|
|
|